服务热线
15339069646服务热线
15339069646| Item | Name | Cat. No. | Tag/Conjugates |
| Anti-CD40LG/CD154 mAbs [Letolizumab Biosimilar] (MABL-4865) | MABL-4865 | ELISA, FACS, Functional assay, in vivo binding | G1, na |
| Anti-IL6R/CD126 mAbs [Levilimab Biosimilar] (MABL-4866) | MABL-4866 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF10B/CD262/DR5/TRAILR2 mAbs [Lexatumumab Biosimilar] (MABL-4867) | MABL-4867 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-Hepatitis B Virus Surface Antigen mAbs [Libevitug Biosimilar] (MABL-4868) | MABL-4868 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-Hepatitis B Virus Surface Antigen mAbs [Libivirumab Biosimilar] (MABL-4869) | MABL-4869 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNF/TNFA mAbs [Licaminlimab Biosimilar] (MABL-4870) | MABL-4870 | ELISA, FACS, Functional assay, in vivo binding | na, Lambda |
| Anti-SLC34A2 mAbs [Lifastuzumab Biosimilar] (MABL-4871) | MABL-4871 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IGHE mAbs [Ligelizumab Biosimilar] (MABL-4872) | MABL-4872 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IAP/CD47 mAbs [Ligufalimab Biosimilar] (MABL-4873) | MABL-4873 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-CD37 mAbs [Lilotomab Biosimilar] (MABL-4874) | MABL-4874 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TGFB1 mAbs [Linavonkibart Biosimilar] (MABL-4875) | MABL-4875 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-LY6G6D/G6D/NG25/LY6-D/MEGT1/C6orf23;CD3E mAbs [Linclatamig Biosimilar] (MABL-4876) | MABL-4876 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa;Kappa |
| Anti-SIGLEC3/CD33/p67 mAbs [Lintuzumab Biosimilar] (MABL-4877) | MABL-4877 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF17/CD269/BCMA/TNFRSF13A;CD3E mAbs [Linvoseltamab Biosimilar] (MABL-4878) | MABL-4878 | ELISA, FACS, Functional assay, in vivo binding | G4;G4, Kappa;Kappa |
| Anti-Zaire Ebolavirus Glycoprotein mAbs [Larcaviximab Biosimilar] (MABL-4846) | MABL-4846 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL5 mAbs [Lasrekibart Biosimilar] (MABL-4847) | MABL-4847 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDCD1/CD279/PD1 mAbs [Latikafusp Biosimilar] (MABL-4848) | MABL-4848 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-SORT1/Gp95/NT3 mAbs [Latozinemab Biosimilar] (MABL-4849) | MABL-4849 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-SLC39A6/ZIP6 mAbs [Laventatug Biosimilar] (MABL-4850) | MABL-4850 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL13 mAbs [Lebrikizumab Biosimilar] (MABL-4851) | MABL-4851 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn